We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients With COPD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2008 by Hospital Hietzing.
Recruitment status was:  Enrolling by invitation
Sponsor:
ClinicalTrials.gov Identifier:
NCT00469313
First Posted: May 4, 2007
Last Update Posted: May 22, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Hospital Hietzing
  Purpose
Hypothesis:benefits of inspiratory muscle strenght training with Respifit S decreases symptoms, disability or handicap of patients affected by COPD. The inspiratory fraction (inspiratory capacity IC/ total lung capacity TLC)may be functionally more representative than other traditional indices.

Condition
COPD

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Efficacy of Inspiratory Muscle Training on Inspiratory Capacity in Patients

Further study details as provided by Hospital Hietzing:

Study Start Date: May 2007
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD GOLD II-III (FEV1<80 and >30%)

Exclusion Criteria:

  • Pregnancy
  • Lung cancer
  • Diabetes mellitus
  • Primary exacerbation of COPD
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00469313


Locations
Austria
Hospital Hietzing
Vienna, Austria, 1130
Sponsors and Collaborators
Hospital Hietzing
Investigators
Study Chair: Michael Reiter Hospital Hietzing, A 1130, Vienna, Austria
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00469313     History of Changes
Other Study ID Numbers: L1234
First Submitted: May 2, 2007
First Posted: May 4, 2007
Last Update Posted: May 22, 2008
Last Verified: May 2008

Keywords provided by Hospital Hietzing:
copd
inspiratory muscle training
IF

Additional relevant MeSH terms:
Respiratory Aspiration
Respiration Disorders
Respiratory Tract Diseases
Pathologic Processes


To Top